Pharmacological characterization of dopamine receptors in parasympathetic innervation of rat heart

1991 ◽  
Vol 200 (1) ◽  
pp. 59-63 ◽  
Author(s):  
Jacques Roquebert ◽  
Asuncion Moran ◽  
Patricia Demichel ◽  
Marie-Frédérique Sauvage
Keyword(s):  
Dopamine Receptors ◽  
Rat Heart ◽  
Parasympathetic Innervation ◽  
Pharmacological Characterization

Pharmacological characterization of 5-HT receptors in parasympathetic innervation of rat heart

1994 ◽  
Vol 252 (2) ◽  
pp. 161-166 ◽  
Author(s):  
Asunción Morán ◽  
Cristina Velasco ◽  
Maria-Luisa Martín ◽  
Luis San Román
Keyword(s):  
Rat Heart ◽  
Parasympathetic Innervation ◽  
Pharmacological Characterization

Pharmacological characterization of dopamine receptors in the rice striped stem borer, Chilo suppressalis

2017 ◽  
Vol 83 ◽  
pp. 80-93 ◽  
Author(s):  
Gang Xu ◽  
Shun-Fan Wu ◽  
Gui-Xiang Gu ◽  
Zi-Wen Teng ◽  
Gong-Yin Ye ◽  
...  
Keyword(s):  
Dopamine Receptors ◽  
Stem Borer ◽  
Chilo Suppressalis ◽  
Pharmacological Characterization

scholarly journals The History and Pharmacology of Dopamine Agonists

1984 ◽  
Vol 11 (S1) ◽  
pp. 118-123 ◽  
Author(s):  
X. Lataste
Keyword(s):  
Dopamine Receptors ◽  
Dopamine Agonists ◽  
Prolactin Secretion ◽  
Regulatory Mechanisms ◽  
Endocrine Disorders ◽  
Dopaminergic Agonists ◽  
Pharmacological Characterization ◽  
Ergot Derivatives ◽  
Dopaminergic Systems

ABSTRACTThe recognition of the dopaminergic properties of some ergot derivatives has initiated new therapeutical approaches in endocrinology as well as in neurology. The pharmacological characterization of the different ergot derivatives during the last decade has largely improved our understanding of central dopaminergic systems. Their development has yielded valuable information on the pharmacology of dopamine receptors involved in the regulatory mechanisms of prolactin secretion and in striatal functions.The clinical application of such new neurobiological concepts has underlined the therapeutical interest of such compounds either in the control of prolactin-dependent endocrine disorders or in the treatment of parkinsonism. Owing to their pharmacological profiles, dopaminergic agonists represent a valuable clinical option especially in the management of Parkinson’s disease in view of the problems arising from chronic L-Dopa treatment.

Pharmacological characterization of the interactions of 2-methoxy-N-propylnorapomorphine (MNPA) with D2 and D3 dopamine receptors

NeuroImage ◽  
2008 ◽  
Vol 41 ◽  
pp. T140
Author(s):  
Mette Skinbjerg ◽  
Y. Namkung ◽  
C. Halldin ◽  
R.B. Innis ◽  
D.R. Sibley
Keyword(s):  
Dopamine Receptors ◽  
Pharmacological Characterization

Pharmacological characterization of D1 and D2 dopamine receptors in rat limbocortical areas. I. Frontal cortex

1988 ◽  
Vol 87 (3) ◽  
pp. 247-252 ◽  
Author(s):  
Enzo Nisoli ◽  
Mariagrazia Grilli ◽  
Maurizio Memo ◽  
Cristina Missale ◽  
PierFranco Spano
Keyword(s):  
Frontal Cortex ◽  
Dopamine Receptors ◽  
Pharmacological Characterization ◽  
D2 Dopamine Receptors
Sign in / Sign up

Export Citation Format

Share Document